12 results on '"Mika, J."'
Search Results
2. Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound
- Author
-
Pohjolainen, Lotta, Kinnunen, Sini M., Auno, Samuli, Kiriazis, Alexandros, Pohjavaara, Saana, Kari-Koskinen, Julia, Zore, Matej, Jumppanen, Mikael, Yli-Kauhaluoma, Jari, Talman, Virpi, Ruskoaho, Heikki, and Välimäki, Mika J.
- Published
- 2024
- Full Text
- View/download PDF
3. GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line
- Author
-
Välimäki, Mika J., Leigh, Robert S., Kinnunen, Sini M., March, Alexander R., de Sande, Ana Hernández, Kinnunen, Matias, Varjosalo, Markku, Heinäniemi, Merja, Kaynak, Bogac L., and Ruskoaho, Heikki
- Published
- 2021
- Full Text
- View/download PDF
4. Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
- Author
-
Claus Bachert, P. V. Tomazic, Peter Hellings, Paloma Campo, Claire Hopkins, Glenis Scadding, Ralph Mösges, Philippe Gevaert, Laura Pujols, Arnout Jordens, Sanna Toppila-Salmi, Valérie Hox, Joaquim Mullol, Carmen Rondon, Koen Boussery, Thibaut Van Zele, Mika J. Mäkelä, Kristian Aasbjerg, Martin Wagenmann, Ioana Agache, Michael Rudenko, Wytske Fokkens, Ludger Klimek, Evelijn Lourijsen, Job F M van Boven, Sophie Scheire, Isam Alobid, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, and UCL - (SLuc) Service d'oto-rhino-laryngologie
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,business.industry ,Immunology ,MEDLINE ,Correction ,RC581-607 ,Term (time) ,Harm ,Immunology and Allergy ,Medicine ,Position paper ,Immunologic diseases. Allergy ,business ,Intensive care medicine - Abstract
An amendment to this paper has been published and can be accessed via the original article.
- Published
- 2020
5. A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
- Author
-
Paula Kauppi, Auli Hakulinen, Emma Kotisalmi, Sanna Toppila-Salmi, and Mika J. Mäkelä
- Subjects
medicine.medical_specialty ,Allergy ,Exacerbation ,Omalizumab ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Reslizumab ,Internal medicine ,medicine ,Corticosteroid ,Biological therapy ,030223 otorhinolaryngology ,Asthma ,Anti-IgE ,lcsh:RC705-779 ,business.industry ,Research ,Organic Chemistry ,Correction ,lcsh:Diseases of the respiratory system ,Anti-IL5 ,medicine.disease ,Benralizumab ,Clinical trial ,Eosinophils ,Chronic rhinosinusitis ,030228 respiratory system ,chemistry ,IgE ,business ,Mepolizumab ,medicine.drug - Abstract
Background Anti-IgE (omalizumab) and anti-IL5/IL5R (reslizumab, mepolizumab and benralizumab) treatments are available for severe allergic and eosinophilic asthma. In these patients, studies have shown beneficial effects in oral corticosteroid use and exacerbations. The aim of this retrospective single-center study was to evaluate the effect of biological therapy on severe asthma and to compare different therapies. Methods We collected and analysed results of anti-IL5/IL5R and anti-IgE therapies for asthma from January 2009 until October 2019 in specialized care. We compared number of exacerbations, asthma symptoms and use of per oral corticosteroids and antimicrobics because of asthma before and during biological therapy, and in a separate analysis need for per oral corticosteroids, antimicrobics or surgery due to upper respiratory tract diseases in asthmatics receiving biologicals. The analyses were done using the Chi square test, T-test or Mann-Whitney U -test, the Kruskall-Wallis test or the Wilcoxon test. Results Of 64 patients, 40 used continuous per oral corticosteroid therapy prior to biological therapy. The mean daily dose of per oral corticosteroid was reduced in those with anti-IL5/IL5R therapy (− 3.0 mg, p = 0.02). The number of annual per oral corticosteroid courses decreased in both the anti-IL5/IL5R (− 2.8 courses, p p p = 0.04) and total number of exacerbation events (− 4.4 events/year, p Conclusions Results with biological therapies in this real-life clinical setting are comparable to those reported in clinical trials. Biological therapy reduces exacerbations and per oral corticosteroid use. Trial registration NCT04158050, retrospectively registered 6.11.2019.
- Published
- 2020
6. Abstracts from the 11th Symposium on Experimental Rhinology and Immunology of the Nose (SERIN 2017)
- Author
-
Ji Heui Kim, Isam Alobid, Francesco Cinetto, Dejan Tomljenovic, Yong Ju Jang, Pascal Haimerl, Elena Savlevich, Roberto Padoan, Raquel Jurado, Tanzeela Hanif, Guy E. Boeckxstaens, Anton Jult, Rainer Jund, Miguel Blanca, Margot Berings, Sanna Toppila-Salmi, Claudia Zanotti, Jean Kim, Rami J. Salib, Adam Chaker, Tomislav Gregurić, Leonid Gaganov, T.C. Biggs, John Ellis, Tengchin Wang, Jonathan Kilimajer, Pirkko Mattila, Lina Mayorga, Natalia Blanca-López, Luisa Galindo, Ji Youn Lim, Sylvia L.F. Pender, Hakan Ucar, César Picado, Carsten B. Schmidt-Weber, Mireya Fuentes-Prado, Achim G. Beule, Magdalena Herknerova, Yvonne Schober, Anita Topic, Tiago Jacinto, Bart Lambrecht, Yvonne Resch, Livije Kalogjera, Kees van Drunen, Chiejun Wu, Rudolf Valenta, Ayumi Fukuoka, Nada Vrkic, Xin Ding, Sven Seys, Patricija Bankovic Radovanovic, Philip G. Harries, Gino Marioni, Marc P. van der Schee, Anna S. Pelkonen, Philip Ghekiere, Ana Prieto, Ivânia Gonçalves, Philippe Gevaert, Luís Araújo, Ruth Murray, Naruhito Iwasaki, Pär Stjärne, Robin Temmerman, Katleen Martens, Rudolf Hagen, Risto Renkonen, Andreas Nockher, Sakari Joenväärä, Claus Bachert, Miguel Gonzalez-Visiedo, Natalie De Ruyck, Wolfgang Pohl, Susanne Vrtala, Peter Hellings, Sonja Schindela, Taiyo Morikawa, Ana Molina, Victor Egorov, Joaquim Mullol, Matti Kankainen, Brecht Steelant, Jutta Renkonen, Giuseppe Brescia, Sung Hee Kim, Mariana Couto, Ibon Eguiluz Gracia, Rita Amaral, Stefania Arasi, Hanne Vermeulen, Raffaella Neri, María José Torres, Kuan-Wei Chen, Stephan Hackenberg, Shigeharu Fujieda, Christian Lupinek, Stephen M. Hayes, Serena Perna, Maria Kochnova, Ana Pereira, Cristobalina Mayorga, Jordi Roca-Ferrer, Kazufumi Matsushita, Borja Callejas, Mika J. Mäkelä, Tamar Smulders, Maria Perez-Gonzalez, Maria Carmen Plaza, Franco Schiavon, Jie Shen Fok, Tomohiro Yoshimoto, Ilaria Caputo, Ranbir Kaulsay, Gabriele Holtappels, Laura Pujols, Bart N. Lambrecht, Ana Maria Prieto, Paloma Campo, Carmen Rondon, Melissa Dullaers, Antonio Valero, Danielle van Egmond, Julia Esser-von Bieren, Lara Derycke, Daniela Cangiano, Paula Kauppi, Hyun Sil Lee, João Fonseca, Pascal Ickrath, Norbert Kleinsasser, Carlo Agostini, Paolo Maria Matricardi, Niklas Beyersdorf, and Gabriela Canto
- Subjects
Pulmonary and Respiratory Medicine ,Rhinology ,medicine.medical_specialty ,medicine.anatomical_structure ,business.industry ,Immunology ,medicine ,Immunology and Allergy ,business ,Meeting Abstracts ,Nose - Published
- 2017
7. Common environmental chemicals do not explain atopy contrast in the Finnish and Russian Karelia
- Author
-
Erkki Vartiainen, Pekka Jousilahti, Tari Haahtela, Jyri-Pekka Koskinen, Mika J. Mäkelä, Leena von Hertzen, Tiina Laatikainen, Tiina Vlasoff, Hannu Kiviranta, School of Medicine / Public Health, Department of Dermatology, Allergology and Venereology, and Clinicum
- Subjects
Pulmonary and Respiratory Medicine ,Intoxicative inhalant ,Pediatrics ,medicine.medical_specialty ,Allergy ,Atopic allergy ,Immunology ,CHILDREN ,010501 environmental sciences ,Brief Communication ,01 natural sciences ,Atopy ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,medicine ,Immunology and Allergy ,PERSISTENT ORGANIC POLLUTANTS ,Food allergens ,Finnish Karelia ,Prenatal exposure ,PRENATAL EXPOSURE ,0105 earth and related environmental sciences ,Asthma ,business.industry ,Test response ,medicine.disease ,3. Good health ,body regions ,Environmental chemicals ,030228 respiratory system ,13. Climate action ,3121 General medicine, internal medicine and other clinical medicine ,ASTHMA ,Russian Karelia ,business ,geographic locations - Abstract
Article, Background Atopic allergy is much more common in Finnish compared with Russian Karelia, although these areas are geographically and genetically close. To explore the role of environmental chemicals on the atopy difference a random sample of 200 individuals, 25 atopic and 25 non-atopic school-aged children and their mothers, were studied. Atopy was defined as having at least one positive skin prick test response to 14 common inhalant and food allergens tested. Concentrations of 11 common environmental pollutants were measured in blood samples. Results Overall, the chemical levels were much higher in Russia than in Finland, except for 2,2′,4,4′-tetra-bromodiphenyl ether (BDE47). In Finland but not in Russia, the atopic children had higher concentrations of polychlorinated biphenyls and 1,1-Dichloro-2,2-bis-(p-chlorophenyl)-ethylene (DDE) than the non-atopic children. In Russia but not in Finland, the atopic mothers had higher DDE concentrations than the non-atopic mothers. Conclusions Higher concentrations of common environmental chemicals were measured in Russian compared with Finnish Karelian children and mothers. The chemicals did not explain the higher prevalence of atopy on the Finnish side., published version, http://purl.org/eprint/status/PeerReviewed
- Published
- 2016
8. Immunohistology and remodeling in fatal pediatric and adolescent asthma.
- Author
-
Malmström, Kristiina, Lohi, Jouko, Sajantila, Antti, Jahnsen, Frode L., Kajosaari, Merja, Sarna, Seppo, and Mäkelä, Mika J.
- Subjects
IMMUNOHISTOCHEMISTRY ,ASTHMA treatment ,HISTOPATHOLOGY ,EOSINOPHILIC esophagitis ,BASAL lamina ,PEDIATRICS ,THERAPEUTICS ,ASTHMA-related mortality ,ASTHMA ,RESPIRATORY mucosa ,RESPIRATORY organ physiology ,STATISTICAL sampling ,SMOOTH muscle - Abstract
Background: Thickening of reticular basement membrane, increased airway smooth muscle mass and eosinophilic inflammation are found in adult fatal asthma. At the present study the histopathology of fatal paediatric and adolescent asthma is evaluated.Methods: Post-mortem lung autopsies from 12 fatal asthma cases and 8 non-asthmatic control subjects were examined. Thickness of reticular basement membrane (RBM) and percentage of airway smooth muscle (ASM%) mass area were measured and inflammatory cells were counted. Patient records were reviewed for clinical history.Results: The age range of the cases was from 0.9 to 19.5 years, eight were males and five had received inhaled corticosteroids. Thickened RBM was detected in majority of the cases without any correlation to treatment delay, age at onset of symptoms or diagnosis. In the large airways ASM was clearly increased in one third of the cases whereas the median ASM% did not differ from that in healthy controls (14.0% vs. 14.0%). In small airways no increase of ASM was found, instead mucous plugs were seen in fatal asthma. The number of eosinophils, plasmacytoid dendritic cells, macrophages, and B-cells were significantly increased in fatal asthma cases compared with controls and the two latter correlated with the length of the fatal exacerbation.Conclusions: The findings highlight the strong presence of eosinophils and mucous plugs even in small airways in children and adolescents with fatal asthma. Thickened RBM was obvious in majority of the patients. Contrary to our hypothesis, increased ASM% was detected in only one third of the patients. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
9. PD27 - Specific antibodies in oral immunotherapy for cow’s milk allergy: kinetics and prediction of clinical outcome
- Author
-
Mika J. Mäkelä, Emma M. Savilahti, Erkki Savilahti, and Mikael Kuitunen
- Subjects
Pulmonary and Respiratory Medicine ,Allergy ,Oral immunotherapy ,business.industry ,Immunology ,food and beverages ,Bioinformatics ,medicine.disease ,Specific antibody ,Cow's milk allergy ,medicine ,Immunology and Allergy ,Poster Discussion Presentation ,business - Published
- 2014
10. PD50 - Impaired lung function in asthmatic schoolchildren – evaluation of risk factors
- Author
-
Hanna Knihtilä, Mika J. Mäkelä, Anna S. Pelkonen, Pekka Malmberg, and Anne Kotaniemi-Syrjänen
- Subjects
Pulmonary and Respiratory Medicine ,Spirometry ,Pediatrics ,medicine.medical_specialty ,Multivariate analysis ,medicine.diagnostic_test ,business.industry ,Birth weight ,Immunology ,Retrospective cohort study ,respiratory system ,medicine.disease ,respiratory tract diseases ,Low birth weight ,FEV1/FVC ratio ,medicine ,Oscillometry ,Immunology and Allergy ,medicine.symptom ,Poster Discussion Presentation ,business ,Asthma - Abstract
In this retrospective study we investigated risk factors for impaired lung function based on medical records of asthmatic children treated in a tertiary hospital between October 2004 and December 2008. Baseline characteristics, lung function measurements and current medication were charted. Those 430 children with data on ≥2 lung function measurements performed ≥5 years apart, were included in the analyses. Altogether 91 (21%) children had abnormal findings in the first lung function measurement (n=38/265 in oscillometry performed at the median age of 4.2 years, and n=53/165 in spirometry performed at the median age of 7.6 years) and 183 (43%) in the last spirometry performed at the median age of 13.8 years. There were significant correlations between the oscillometry and last spirometry parameters: r=-0.243 between R5 z-score and FEV1 (p
- Published
- 2014
11. Feasibility and antihypertensive effect of replacing regular salt with mineral salt -rich in magnesium and potassium- in subjects with mildly elevated blood pressure.
- Author
-
Sarkkinen, Essi S, Kastarinen, Mika J, Niskanen, Tarja H, Karjalainen, Pia H, Venäläinen, Taisa M, Udani, Jay K, and Niskanen, Leo K
- Abstract
Background: High salt intake is linked to hypertension whereas a restriction of dietary salt lowers blood pressure (BP). Substituting potassium and/or magnesium salts for sodium chloride (NaCl) may enhance the feasibility of salt restriction and lower blood pressure beyond the sodium reduction alone. The aim of this study was to determine the feasibility and effect on blood pressure of replacing NaCl (Regular salt) with a novel mineral salt [50% sodium chloride and rich in potassium chloride (25%), magnesium ammonium potassium chloride, hydrate (25%)] (Smart Salt).Methods: A randomized, double-blind, placebo-controlled study was conducted with an intervention period of 8-weeks in subjects (n = 45) with systolic (S)BP 130-159 mmHg and/or diastolic (D)BP 85-99 mmHg. During the intervention period, subjects consumed processed foods salted with either NaCl or Smart Salt. The primary endpoint was the change in SBP. Secondary endpoints were changes in DBP, daily urine excretion of sodium (24-h dU-Na), potassium (dU-K) and magnesium (dU-Mg).Results: 24-h dU-Na decreased significantly in the Smart Salt group (-29.8 mmol; p = 0.012) and remained unchanged in the control group: resulting in a 3.3 g difference in NaCl intake between the groups. Replacement of NaCl with Smart Salt resulted in a significant reduction in SBP over 8 weeks (-7.5 mmHg; p = 0.016). SBP increased (+3.8 mmHg, p = 0.072) slightly in the Regular salt group. The difference in the change of SBP between study groups was significant (p < 0.002).Conclusions: The substitution of Smart Salt for Regular salt in subjects with high normal or mildly elevated BP resulted in a significant reduction in their daily sodium intake as well as a reduction in SBP. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
12. The appropriateness of DUNDRUM-3 and DUNDRUM-4 for Māori in forensic mental health services in New Zealand: participatory action research.
- Author
-
Wharewera-Mika J, Cooper E, Wiki N, Prentice K, Field T, Cavney J, Kaire D, and McKenna B
- Subjects
- Ethnicity, Female, Humans, Ireland, Male, New Zealand, Forensic Medicine, Health Services Research, Mental Disorders therapy, Mental Health Services, Native Hawaiian or Other Pacific Islander
- Abstract
Background: The Auckland Regional Forensic Psychiatry Services (ARFPS) in New Zealand has introduced structured clinical judgment instruments developed in Ireland (DUNDRUM-3 and DUNDRUM-4) to assist staff decision-making regarding service users' clinical pathways. In New Zealand, Māori (the indigenous people) constitute 43% of the in-patient forensic mental health population. The aim of this study was to determine the face validity of the measures for Māori., Methods: Participatory Action Research was aligned with a kaupapa Māori (Māori-orientated) research approach, to give full recognition to Māori cultural values. Two hui (gatherings) were held with Māori clinical and cultural experts at the service. The first hui (n = 12), explored the cultural appropriateness of the measures. The second (n = 10) involved a reflection on appropriate adaptions to the measures. Discussions were digitally recorded, transcribed and thematically analysed., Results: Although the usefulness of the measures in enhancing the overall quality of clinical decision-making was confirmed, the DUNDRUM measures were considered to be limited in their ability to fully measure Māori service user progress and recovery. Suggestions were made to develop an additional 'pillar' focused on cultural identity and spirituality for DUNDRUM-3; to use both service user and family ratings for the adapted DUNDRUM-3 and DUNDRUM-4 measures; and to involve cultural expertise at the point of structured clinical judgement when using the measures., Conclusions: This is the first study to consider the face validity of the DUNDRUM-3 and DUNDRUM-4 for indigenous peoples, who are internationally over-represented in forensic mental health services. Suggested changes would require a negotiated, collaborative process between Māori cultural expertise and the original authors of the measures.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.